Cargando…

Glucocorticoids Improve Myogenic Differentiation In Vitro by Suppressing the Synthesis of Versican, a Transitional Matrix Protein Overexpressed in Dystrophic Skeletal Muscles

In Duchenne muscular dystrophy (DMD), a dysregulated extracellular matrix (ECM) directly exacerbates pathology. Glucocorticoids are beneficial therapeutics in DMD, and have pleiotropic effects on the composition and processing of ECM proteins in other biological contexts. The synthesis and remodelli...

Descripción completa

Detalles Bibliográficos
Autores principales: McRae, Natasha, Forgan, Leonard, McNeill, Bryony, Addinsall, Alex, McCulloch, Daniel, Van der Poel, Chris, Stupka, Nicole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751232/
https://www.ncbi.nlm.nih.gov/pubmed/29211034
http://dx.doi.org/10.3390/ijms18122629
_version_ 1783289903643099136
author McRae, Natasha
Forgan, Leonard
McNeill, Bryony
Addinsall, Alex
McCulloch, Daniel
Van der Poel, Chris
Stupka, Nicole
author_facet McRae, Natasha
Forgan, Leonard
McNeill, Bryony
Addinsall, Alex
McCulloch, Daniel
Van der Poel, Chris
Stupka, Nicole
author_sort McRae, Natasha
collection PubMed
description In Duchenne muscular dystrophy (DMD), a dysregulated extracellular matrix (ECM) directly exacerbates pathology. Glucocorticoids are beneficial therapeutics in DMD, and have pleiotropic effects on the composition and processing of ECM proteins in other biological contexts. The synthesis and remodelling of a transitional versican-rich matrix is necessary for myogenesis; whether glucocorticoids modulate this transitional matrix is not known. Here, versican expression and processing were examined in hindlimb and diaphragm muscles from mdx dystrophin-deficient mice and C57BL/10 wild type mice. V0/V1 versican (Vcan) mRNA transcripts and protein levels were upregulated in dystrophic compared to wild type muscles, especially in the more severely affected mdx diaphragm. Processed versican (versikine) was detected in wild type and dystrophic muscles, and immunoreactivity was highly associated with newly regenerated myofibres. Glucocorticoids enhanced C2C12 myoblast fusion by modulating the expression of genes regulating transitional matrix synthesis and processing. Specifically, Tgfβ1, Vcan and hyaluronan synthase-2 (Has2) mRNA transcripts were decreased by 50% and Adamts1 mRNA transcripts were increased three-fold by glucocorticoid treatment. The addition of exogenous versican impaired myoblast fusion, whilst glucocorticoids alleviated this inhibition in fusion. In dystrophic mdx muscles, versican upregulation correlated with pathology. We propose that versican is a novel and relevant target gene in DMD, given its suppression by glucocorticoids and that in excess it impairs myoblast fusion, a process key for muscle regeneration.
format Online
Article
Text
id pubmed-5751232
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-57512322018-01-08 Glucocorticoids Improve Myogenic Differentiation In Vitro by Suppressing the Synthesis of Versican, a Transitional Matrix Protein Overexpressed in Dystrophic Skeletal Muscles McRae, Natasha Forgan, Leonard McNeill, Bryony Addinsall, Alex McCulloch, Daniel Van der Poel, Chris Stupka, Nicole Int J Mol Sci Article In Duchenne muscular dystrophy (DMD), a dysregulated extracellular matrix (ECM) directly exacerbates pathology. Glucocorticoids are beneficial therapeutics in DMD, and have pleiotropic effects on the composition and processing of ECM proteins in other biological contexts. The synthesis and remodelling of a transitional versican-rich matrix is necessary for myogenesis; whether glucocorticoids modulate this transitional matrix is not known. Here, versican expression and processing were examined in hindlimb and diaphragm muscles from mdx dystrophin-deficient mice and C57BL/10 wild type mice. V0/V1 versican (Vcan) mRNA transcripts and protein levels were upregulated in dystrophic compared to wild type muscles, especially in the more severely affected mdx diaphragm. Processed versican (versikine) was detected in wild type and dystrophic muscles, and immunoreactivity was highly associated with newly regenerated myofibres. Glucocorticoids enhanced C2C12 myoblast fusion by modulating the expression of genes regulating transitional matrix synthesis and processing. Specifically, Tgfβ1, Vcan and hyaluronan synthase-2 (Has2) mRNA transcripts were decreased by 50% and Adamts1 mRNA transcripts were increased three-fold by glucocorticoid treatment. The addition of exogenous versican impaired myoblast fusion, whilst glucocorticoids alleviated this inhibition in fusion. In dystrophic mdx muscles, versican upregulation correlated with pathology. We propose that versican is a novel and relevant target gene in DMD, given its suppression by glucocorticoids and that in excess it impairs myoblast fusion, a process key for muscle regeneration. MDPI 2017-12-06 /pmc/articles/PMC5751232/ /pubmed/29211034 http://dx.doi.org/10.3390/ijms18122629 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
McRae, Natasha
Forgan, Leonard
McNeill, Bryony
Addinsall, Alex
McCulloch, Daniel
Van der Poel, Chris
Stupka, Nicole
Glucocorticoids Improve Myogenic Differentiation In Vitro by Suppressing the Synthesis of Versican, a Transitional Matrix Protein Overexpressed in Dystrophic Skeletal Muscles
title Glucocorticoids Improve Myogenic Differentiation In Vitro by Suppressing the Synthesis of Versican, a Transitional Matrix Protein Overexpressed in Dystrophic Skeletal Muscles
title_full Glucocorticoids Improve Myogenic Differentiation In Vitro by Suppressing the Synthesis of Versican, a Transitional Matrix Protein Overexpressed in Dystrophic Skeletal Muscles
title_fullStr Glucocorticoids Improve Myogenic Differentiation In Vitro by Suppressing the Synthesis of Versican, a Transitional Matrix Protein Overexpressed in Dystrophic Skeletal Muscles
title_full_unstemmed Glucocorticoids Improve Myogenic Differentiation In Vitro by Suppressing the Synthesis of Versican, a Transitional Matrix Protein Overexpressed in Dystrophic Skeletal Muscles
title_short Glucocorticoids Improve Myogenic Differentiation In Vitro by Suppressing the Synthesis of Versican, a Transitional Matrix Protein Overexpressed in Dystrophic Skeletal Muscles
title_sort glucocorticoids improve myogenic differentiation in vitro by suppressing the synthesis of versican, a transitional matrix protein overexpressed in dystrophic skeletal muscles
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751232/
https://www.ncbi.nlm.nih.gov/pubmed/29211034
http://dx.doi.org/10.3390/ijms18122629
work_keys_str_mv AT mcraenatasha glucocorticoidsimprovemyogenicdifferentiationinvitrobysuppressingthesynthesisofversicanatransitionalmatrixproteinoverexpressedindystrophicskeletalmuscles
AT forganleonard glucocorticoidsimprovemyogenicdifferentiationinvitrobysuppressingthesynthesisofversicanatransitionalmatrixproteinoverexpressedindystrophicskeletalmuscles
AT mcneillbryony glucocorticoidsimprovemyogenicdifferentiationinvitrobysuppressingthesynthesisofversicanatransitionalmatrixproteinoverexpressedindystrophicskeletalmuscles
AT addinsallalex glucocorticoidsimprovemyogenicdifferentiationinvitrobysuppressingthesynthesisofversicanatransitionalmatrixproteinoverexpressedindystrophicskeletalmuscles
AT mccullochdaniel glucocorticoidsimprovemyogenicdifferentiationinvitrobysuppressingthesynthesisofversicanatransitionalmatrixproteinoverexpressedindystrophicskeletalmuscles
AT vanderpoelchris glucocorticoidsimprovemyogenicdifferentiationinvitrobysuppressingthesynthesisofversicanatransitionalmatrixproteinoverexpressedindystrophicskeletalmuscles
AT stupkanicole glucocorticoidsimprovemyogenicdifferentiationinvitrobysuppressingthesynthesisofversicanatransitionalmatrixproteinoverexpressedindystrophicskeletalmuscles